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Bacterial infections associated with mastitis reduce pregnancies in cattle.  Effects 
on pregnancy and incidence of mastitis in sheep were investigated after immunization 
with peptidoglycan-polysaccharide (PG-PS) and killed cells from Strep pyogenes. 
Rambouillet (n=100) and mixed breed (n=18) ewe lambs were immunized (~d42 and 22 
before breeding) with PG-PS (30µgPG/kg/bw) or killed cells or were not immunized 
(Control, n=117).  IgG antibodies were detected by ELISA. Ewes were bred at 
synchronized estrus.  All immunized and half of non-immunized ewes were challenged 
with PG-PS (60µgPG/kg/bw) d5 after breeding.  Although proportion of ewes pregnant at 
d42 did not differ, probability of pregnancy decreased with total dose of PG-PS (p<.05).  
Incidence of mastitis in mixed breed ewes in the middle and at the end of lactation did 
not differ.  In conclusion, immunization of ewe lambs with PG-PS or killed cells of Strep 
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I.  Introduction 
 Breeding efficiency of domestic animals is a composite of several factors, 
including success of ovulation, manifestation of estrus, viability of gametes, fertilization 
rate, embryo survival and fetal development, and perinatal survival rate (Stott and 
Williams, 1962; Dailey et al. 2002).  In cows, fertilization rates of 85 to 90 % have been 
reported (Kidder et al., 1954; Bearen et al., 1956; Hill et al., 1970), but up to 40 % of 
fertilized eggs did not survive through 40 days of gestation, so pregnancy rate was only 
60 % (Tanabe and Casida, 1949; Tanabe and Almquist, 1953).  Many studies were 
designed to estimate the embryonic and fetal loss in bovine.  Great variation exists in the 
data collected due to different end-points of experiments, differences in breeds, locations, 
and farm management.  Dailey et al. (2002) recently reviewed the literature and 
concluded that the majority of the loss occurred at the early embryonic stage, 
corresponding to early blastocyst stage.  In both nonparous and parous beef cows, a large 
proportion of reproductive failure occurred by day 8 of gestation without noticeable 
influence on the estrous cycle length (Maurer and Chenault, 1983). 
 In the dairy industry, the goal is to have cows pregnant again within 90 days of 
calving (Louca and Legates, 1968), which means they must be bred during lactation.  
Lactation itself imposes a high metabolic demand on females.  In addition, mastitis is a 
common problem in dairy cows.  The financial losses due to the inflammation are not 
only in the form of unusable milk, but also due to the negative effect of disease on 
reproductive functions.  
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Cows show greater sensitivity to bacterial pathogens during pregnancy (Apitz et 
al. 1935).  Barker et al. (1998) found that clinical mastitis during early lactation 
negatively influenced reproductive performance of Jersey cows.  Specifically, number of 
artificial inseminations (AI) per conception was greater in cows with clinical mastitis 
after AI than for cows with mastitis before AI or after confirmed pregnancy.   
Many species of bacteria cause mastitis in cows, sheep and goats. The main 
component of the cell wall of Gram-positive bacteria, peptidoglycan, induces the 
inflammatory response in the host. Peptidoglycan has very similar biological actions as 
endotoxin, the main cell wall component of Gram-negative bacteria (Stetson, 1956; 
Rotta, 1975).   
It is of interest to find out how molecules involved in the inflammatory reaction 
caused by peptidoglycan affect early embryonic survival in ruminants.  Moreover, 
immunizing against the bacterial pathogens, using isolated peptidoglycan-polysaccharide 
complex or the whole, dead, Gram-positive bacteria might be possible.  If immunization 
is effective, the negative effect of bacteria on reproductive efficiency and/or mastitis 
could be lessened or abolished.   
II. Early Embryonic Development 
  
A. Morphological  Events 
A mammalian oocyte is a large haploid cell surrounded by a protective 
extracellular layer, the zona pellucida, and by granulosal cells organized into corona 
radiata. Fertilization in mammals triggers the completion of meiotic division of the 
oocyte. After fusion of sperm and oocyte, the diploid chromosome number is restored 
and a complex program of gene activity directs the embryogenesis.  The embryo begins 
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to develop as a cell of about 100 to 150 µm in diameter (Blandau, 1961; Hartman et al., 
1931). The early embryonic processes include cell divisions, cell migrations and 
differentiation, which result in two main cell lineages. One cell lineage will give rise 
solely to extraembryonic support structures, and the other lineage will form the embryo 
proper.   
After fertilization, several mitotic divisions follow, spaced at approximately 12-hr 
intervals. This phase is called cleavage.  There is no cell growth during this time, 
therefore, as cleavage continues, the large volume of the zygotes cytoplasm is divided 
into numerous and smaller cells-blastomeres.  During this time, the embryo is still in the 
oviduct and enclosed by the thick, translucent mucoprotein, zona pellucida.  A crucial 
event, compaction, happens at the eight-cell stage of the mammalian embryo.  The 
blastomeres dramatically increase the cell-to-cell adhesions and flatten upon each other.  
Blastomeres forming the outside layer develop tight junctions between one another and 
initiate the process of epithelial differentiation.  Cell divisions continue. When the 
number of cells reaches sixteen, the embryo is called a morula.  At that time, two distinct 
populations of cells can be recognized, the inner cells connected by gap junctions and the 
outer layer of cells forming an epithelium.  After the next series of mitotic divisions, the 
outer layer of cells, called the trophoblast, facilitates the transport of fluid from outside of 
the embryo to inside and the fluid-filled cavity, blastocoel, is formed.  The embryo at this 
stage is called the blastocyst.    
Very early embryonic development is controlled by the maternal mRNA and 
proteins in most of the domestic species.  The onset of zygotic transcription in mice 
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begins at two cell stage, but in most of the organisms is delayed until the embryo is 
composed of hundreds to thousands of cells (Burdsal, 1999).   
Implantation happens when the embryo becomes actually embedded in uterine 
tissue, or even enclosed by it, as in mice and rats (Enders and Schlafke, 1967).  In all 
species, implantation involves a direct interaction of the trophoblast with the luminal 
epithelium of the uterus (Weitlauf, 1988).  This process is preceded by attachment, which 
begins with apposition of the embryo to the site of implantation (Schlafke and Enders, 
1975).  There is specie-to specie variation with respect to the time, degree, and type of 
attachment at the maternal-fetal interface, as well as the orientation of the blastocyst, 
summarized by Wimsat (1975).  Placenta was defined by Mossman in 1937 as an 
apposition or fusion of tissues from parent and offspring for physiological exchange and 
develops from the trophoblast.  The discrete regions of placenta, which serve as zones of 
metabolic exchange, have the shape of finger-like projections, called chorionic villi. 
Different distribution of chorionic villi on placentas gives basis for the anatomical 
classification of placentas of the various species.  In ruminants, villi are grouped in a 
variable number of structures called cotyledons, therefore the placenta is cotyledonary. 
The actual attachment in horses, pigs and ruminants is of epitheliochorial type, which 
means that maternal endothelial cells of blood vessels, uterine stroma and epithelium, 
then fetal trophoblast epithelium, interstitial cells and endothelial cells are layers that 
physically separate the maternal and embryonal circulations. This is the least intimate 
type of microscopic placental classifications (Senger, 1999).   
Histological examination of cow eggs and embryos by Hamilton and Laing in 
1946 revealed that the fertilized egg in a cow stays in the 1-cell stage for about 27 hours. 
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The transport through the oviduct takes about 96 hours.  When it enters the uterine 
lumen, it is about 8 to 16 cell stage morula, and corresponds to the fifth day post 
ovulation.  The blastocyst is formed about 8 to 9 days after ovulation (Chang, 1952). 
Then the blastocyst floats in the uterus until apposition of the trophoblast to the uterus 
and actual adhesion (Wimsatt, 1975), which take places about 40 days after ovulation in 
the cow (Hamilton and Laing, 1946).  The blastocysts recovered 12 and 13 days after 
ovulation have started to elongate and were described by Chang (1952) as fragile, 
wrinkled and very sticky when pushed by a needle.  In the sheep, the time corresponding 
to the various changes in the morphology and location of the embryo are as follows:  one 
cell stage, 38 hours; morula stage, about 96 hours; morula entering the uterus 2-4 days 
post ovulation, than the blastocyst formation takes place at 5-7 days and implantation at 
17-18 days (Chang and Rowson, 1965; Brinster, 1974).  According to Brinster (1974), 
even though the overall pregnancy length largely differs among mammals (mouse 21 
days, cow 284 days), the time from ovulation till blastocyst stage is quite similar, 3-9 
days.  
B.   Endocrinology of early embryo development 
One of the factors involved in establishment of successful pregnancy is an 
appropriate communication between the fetus and the maternal body.  The embryo needs 
to signal its presence in the uterus, which, in turn, initiates the protective mechanism for 
the developing embryo.  This phenomenon is referred to as maternal recognition of 
pregnancy.  In many species, especially ungulates, a well-known component of the 
maternal protective mechanism is the prolonged functioning of the corpus luteum (CL), 
an endocrine gland formed in the ovary after ovulation of the follicle.  The CL secretes 
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progesterone, which, during pregnancy, prevents cyclicity and ensures quiescence of the 
uterus.  The weights of the uterine endometrium of cycling intact ewes were increased in 
response to early progesterone treatment (Wilson et al., 1972).  Uterus and ovaries thus 
function as endocrine-circuit, as it was demonstrated by increasing the life span of corpus 
luteum after removal of the uterus (Wiltbank and Casida, 1956; Rowson and Moore, 
1964; Inskeep and Butcher, 1966; Thacher et al., 1986; Bazer, 1992), and termination of 
pregnancy soon after removal of ovaries prior to 180-200 days of gestation in bovine 
(Estergreen et al., 1967).  
The signal from embryo to mother is endocrine in nature.  Moore (1968) proposed 
that in the sheep, the stimulus from the embryo has an antiluteolytic rather than 
luteotropic effect on CL.  This corpus luteum life-extending function of the embryo is 
assumed on day 12 to 13 after estrus, two to three days before the CL of non-pregnant 
cycling sheep regress (Henricks et al., 1971).  Regression of the CL during the cycle has 
been found to be associated with uterine prostaglandins (suggested by Babcock in 1966; 
Bland et al., 1971; Wilson et al. 1972; Inskeep and Murdoch, 1980) and from the ovary 
(Rexroad and Guthrie, 1979; Milvae and Hansel, 1983).  This prostaglandin secretion is 
decreased and overcome by the presence of the embryo in the uterus (Kindahl et al., 
1976; Pratt et al., 1977; Betteridge et al., 1984).  Prostaglandins are synthesized from 
arachidonic acid (Granstrőm, 1981) and mediate hemodynamic derangements (Sorrels et 
al., 1971), changes in platelet function (van der Wolf et al., 1978), alterations in vascular 
permeability (Arrora et al., 1970), stimulatory effects on contractility of uterus (Cseply 
and Csapo, 1972; Wiqvist et al., 1972), and influences on the course of inflammatory 
processes (Crunkhorn and Willis, 1969).  Cultured endometrium from uteri at day 17 of 
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gestation produced less prostaglandin F2α (PGF2α) than endometrium from cyclic cows 
on day 17 (Gross et al., 1988).  Day-13 ovine corpus luteum during pregnancy was found 
to have greater enzymatic activity of prostaglandin dehydrogenase (PGDH), which is an 
enzyme metabolizing PGF2α into its inactive form, 15-keto-13,14-dihydro-prostaglandin 
F2α (PGFM), compared to day 13 cyclic ovine corpus luteum (Silva et al., 2000).  
C. Immunology of early maternal-fetal interface 
The morphological and endocrine changes during early embryonic development 
are accompanied by the local and /or systemic presence of numerous bioactive 
compounds besides hormones that regulate or modify the uterine environment to favor 
the embryo.  Many of these compounds are proteins, including growth factors, cytokines 
and adhesion molecules.  Those proteins mediate many processes required for successful 
implantation, yet little is known about mutual interactions and sequence of events 
involving these molecules (Findlay at al., 1979; Sunder and Lenton; 2000). 
Immunological mechanisms associated with early pregnancy involve regulation of the 
invasion of the fetal cells into maternal tissue such that damage to the mother is 
prevented.  Simultaneously, maternal recognition of pregnancy must be orchestrated so 
that allorejection of the fetus does not occur (reviewed by Entrican, 2002).  For 
successful pregnancy, low concentrations of inflammatory cytokines, such as tumor 
necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ), but predominance of 
regulatory cytokines as interleukin (IL) -10 (IL-10) and transforming factor-beta (TGF-
β), are necessary (Entrican, 2002).  In pathological situation for instance, infection, 
inflammatory cytokines may increase in concentration and endanger the pregnancy.  A 
mice model of spontaneous embryo resorption (CBA mated to DBA/2 mice) had 
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provided valuable information on role of cytokines in the materno-fetal interface.  Tangri 
and Raghupathy (1993) demonstrated that placentas of the resorption-prone mating 
combination (CBA x DBA/2) had enhanced expression of TNF-α, IFN-τ, and interleukin-
2 (IL-2, inflammatory cytokine), when compared to placentas obtained from non-
resorption-prone combination (CBA x BALB/c).  TNF-α is involved in trombosis and 
smooth muscle contraction.  IFN-τ may have both beneficial (reviewed by Hansen 1995; 
Bazer et al., 1997; Martal et al., 1997) or detrimental effects (Tangri and Raghupathy, 
1993), which may depend on the species and stage of pregnancy (Entrican, 2002).  Pro-
inflammatory cytokine IL-12 is mediating immune response leading to the generation of 
T cells with a T helper 1 (Th-1)-type cytokine profile.  On the other hand, T cells which 
express Th2-type cytokine profile are activated under the influence of IL-4 and are 
effective in antibody response.  A balance of inflammatory and regulatory cytokines is 
necessary for protection against infectious disease as well as for not causing the damage 
to the host and embryo (Entrican, 2002).  
III. Early Embryonic Loss  
Loss of pregnancy is a serious problem resulting in financial losses for dairy 
producers.  Robinson (1977) pointed out that only 50 to 55% of healthy breeder cows in 
which eggs were fertilized using artificial insemination, calved.  Diskin and Sreenan 
(1980) examined 256 Aberdeen Angus and Hereford cross breds and found that in 
genitally normal heifers, fertilization failure accounted for 10% of overall reproductive 
failure, while embryo death accounted for more then 30%.  Most of the embryonic 
mortality occurred between days 8 and 16 of gestation.  A study of variability in fertility 
of bulls affecting the fertilization rates and embryonic mortality of Holstein and Guernsey 
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heifers by Kidder et al. (1954) showed that high fertility bulls, based on nonreturn rate 
70% and above, had a100% fertilization rate and estimated embryonic death rate of 24 %.  
Several factors cause early embryonic death.  Besides genetic and endocrine bases, 
disease at the time of early embryonic development can adversely affect survival of the 
embryo.   
IV. Mastitis 
A. Prevalence and Economical Losses  
Mastitis, inflammation of the mammary gland, is a significant cause of financial 
losses in the dairy industry, and it has a negative impact on reproductive efficiency.  The 
USDA report in 1954 showed the estimated loss of $225,804,000 (USDA, 1954) and at 
least $2 billion in 1993 (DeGraves and Fetrow, 1993) to mastitis in the United States.  In 
other words, 10-11 % of total productive capacity was lost per year, when producers took 
in to consideration decreased milk production, increased replacement cost, discarded 
milk, cost of drugs, veterinary fees, and labor costs.  Erb et al. (1985) estimated in 33 
dairy herds that bovine mastitis together with failure to conceive at first service increased 
risk of culling 5.2 to 10 times.  Similarly, ovine mastitis is causing significant problems 
on milking sheep farms and in the sheep milk cheese industry worldwide, especially in 
Mediterranean countries.  A study of 17 sheep flocks of the Manchega breed and 5 flocks 
of the Assaf breed in central Spain revealed that subclinical mastitis oscillated from 9 to 
83 % of animals with an average of 35 %, and between 4.5 and 67% of mammary glands 
with the a mean of 21 % (Las Heras et al., 2001).  These values were similar to reports 
from northern Greece (Stefanakis et al, 1995) and Portugal (cited in Las Heras et al., 
2001), but slightly higher than those from Italy (cited in Las Heras et al., 2001) and 
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England (Watkins et al., 1991). In the United States, with a relatively smaller 
socioeconomic importance of the sheep-cheese industry, the primary concern due to 
mastitis is the negative effect on lamb growth.  Keisler at al. (1992) examined subclinical 
mastitis of Hamphire and Finn x Dorset x Rambouillet crossbred sheep and found that 
incidence of inflammation was from 17 to 50 %.  The same group also found that the 
subclinical mastitis had no effect on lamb growth.  However, this was at day 40 
postpartum, and lambs had access to supplemental feed.   
B. Clinical Classifications  
The primary cause of mastitis is bacterial infection, which results from passage of 
the microorganism through the teat canal, either by growth or by suction during milking 
(Plastridge, 1958). After infection, inflammation results in changes in udder secretions 
and glandular tissue that may or may not be associated with clinical signs of mastitis. 
Subclinical mastitis means that neither swelling of the udder is detected nor is there 
observable abnormalities in the milk, but via special screening tests, number of somatic 
cells in the milk would be increased (Swartz, 2001).  Milk somatic cells consist of 
neutrophils, macrophages, lymphocytes, and epithelial cells (Sordillo et al., 1997) that are 
released into the milk in exceedingly high concentration when the mammary gland is 
inflamed.  Microscopic evaluation of milk or using the on-site screening tests such as 
California Mastitis Test (CMT), Wisconsin Mastitis Test (WMT) or the catalase test, 
detect the number of such immune (somatic) cells in the milk.  This provides valuable 
health and market-related information about the cow and milk, and is called a somatic 
cell count (SCC).  Blosser (1979) concluded that most of the losses due to mastitis are 
attributed to subclinical mastitis.  Clinical mastitis is the presence of white blood cells in 
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the milk and can be mild or acute (severe).  In the case of mild clinical mastitis, cells 
clumped as flakes and clots, give an unusual appearance of milk. Acute clinical mastitis is 
painful to the animal; the udder is hot and very sensitive, fever and loss of appetite may 
occur.  Somatic cell counts and clinical mastitis have positive genetic correlation 
(Kadarmideen and Pryce, 2001).  Chronic mastitis is a persistent udder infection.   
C. Mastitis Pathogens 
The organisms most commonly involved in mastitis include both gram-positive 
and gram-negative bacterial species, like Escherichia coli, Micrococcus aureus, 
Micrococcus pyogenes, Staphylococcus aureus,  Staphylococcus pyogenes, Nocardia, 
Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus equines, 
Streptococcus pyogenes, Streptococcus hemoliticus, Streptococcus uberis, Streptococcus 
zooepidemicus, Arcanobacterium pyogenes, Corynebacterium bovis, Klebsiella 
pneumonidae, and also yeast (Law, 1923; Brown et al., 1926; Schalm, 1963; Gonzales et 
al.,1990; Moore et al., 1991; Barker et al., 1998; Waage et al., 1998).  Streptococcal 
(Strep) species of different origin were found frequently in raw and pasteurized milk 
(Brown et al., 1926).  It was of interest, whether the milk-borne Strep pathogens could 
cause septic sore throat epidemics.  Smith with Brown (1915) advanced the theory that 
the human sore throat epidemics were not caused by the Strep which usually cause 
bovine mastitis, but by Strep of human origin that occasionally enters the udder of a cow.  
Davis and Capps (1914) infected cows udder with human streptococci by rubbing the 
culture on abraded teat. Brown et al. (1926) found Beta hemolytic streptococci in 
considerable numbers in certified milk from five dairy herds representing about 900 dairy 
cows in Wisconsin.  However, there was no evidence that any of them were pathogenic to 
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humans.  Plastridge (1958) pointed out that there are three main principal organisms 
associated with bovine mastitis, Gram-positive Strep agalactiae, Strep uberis and 
Micrococcus Pyogenes, which usually cause chronic mastitis.  DeGraves and Fetrow 
(1993) summarized the organisms involved in subclinical mastitis, caused by contagious 
bacteria as Strep agalactiae and Staphylococcus (S.) aureus, or by environmental 
organisms such as nonagalactiae  Strep species, usually Strep uberis or Strep 
dysgalactiae.  Barker et al. (1998) found environmental Streptococcal species more 
prevalent than E. Coli or other Gram-negative pathogens in a herd of Jersey dairy cows.  
In the 2001 newsletter of National Mastitis Council, producers were informed that the 
most frequently isolated Strep from bovine mammary gland is Strep uberis.  Coliform 
mastitis is caused by Gram-negative bacteria that include E. coli, Klebsiella spp., and 
Enterobacter spp. (Harmon, 1994).  The main microorganisms producing subclinical 
mastitis in milking sheep are S. epidermis, then Strep agalactiae, Strep uberis, and Strep 
dysgalactiae (Fernández-Garayzábal et al, 1998).  
D. Effect of Mastitis on Physiology and Reproduction 
Paape et al. (1974) induced acute coliform mastitis using E. coli endotoxin and 
noticed dynamic changes within a short time after infusion.  A rapid decrease in 
concentration of circulating neutrophils was detected within 90 minutes.  The extra 
vascular mobilization of neutrophils into mammary tissue was noticed in 3 hours by 
increased somatic cell counts in milk, which peaked in 18-24 hours at 1000-fold. 
Swelling of the udder in two hours suggested over-population and lysis of blood 
neutrophils.  Increase in body temperature was critical between four and six hours post 
infusion.  An increase in plasma corticosteroid concentration was detected at two hours, 
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peaked at four hours and returned to normal by two hours.  Giri et al. (1984) also 
recognized a rapid increase of somatic cells in milk, as well as a significant increase of 
bovine serum albumin in whey after instillation of 50 µg of endotoxin into teats of cows.   
Fever, as a component of inflammatory reaction to acute mastitis, also may have 
an effect on the oocyte and on the embryo.  Lavický et al. (1988) recorded fever response 
when components of bacterial cell wall were given intravenously to 12-40 days old 
calves at a dose of 50 µg/kg body weight.  Moor and Crosby (1985) hypothesized and 
found that temperature fluctuation in mammalian oocytes during maturation adversely 
affected their subsequent developmental potential, as the cooling of ovine oocytes slowed 
meiosis.  Fever and hyperthermia may affect embryo survival.  Ealy et al. (1994) found 
increases in pregnancy rates of heat-stressed cows in Florida when cows were cooled 
from two to three days before until five to six days after breeding.  A fever response was 
observed in lactating dairy cows four and half and six hours after intravenous and 
intramammary endotoxin infusion (Jackson et al, 1990).  However, Barker (1999) did not 
find reduction in pregnancy rate to be associated with fever, when sheep were challenged 
with peptidoglycan-polysaccharide intravenous injection day 5 after breeding.  
Sordilo et al. (1997) pointed out that cytokines, which are released during 
pathological conditions associated with mastitis, are extremely potent molecules, which, 
at elevated levels, may be detrimental to the host.  The physiological alterations of 
homeostasis associated with mastitis have been related to decreased reproductive 
efficiency, including early embryonic loss (Barker et al, 1998, Loeflerr et al. 1999; Oliver 
et al., 2001).  Loeffler et al. (1999) studied effects of diseases on fertility in dairy cows in 
the Netherlands and found that the impact of the disease depended strongly on time since 
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the disease last occurred.  In the case of clinical mastitis, its impact on conception was 
very weak if occurring prior to artificial insemination (AI), but caused greater than 50 % 
reduction in pregnancy risk if occurred 3 weeks after AI. 
V. Bacterial Cell Wall, Lipopolysacharide and Peptidoglycan  
A. Chemical Structure 
Most bacterial cells have three main regions: cytoplasm, cell envelope and cell 
appendages (proteins in the form of fimbriae and flagella), reviewed by Todar (2002). 
The cell envelope consists of plasma membrane, cell wall and capsule.  Capsule is the 
outside layer made of polysaccharide, known to mediate adherence of bacteria to 
particular surfaces.  The cell wall is an essential structure protecting bacteria from 
osmotic lysis.  The main constituent of the cell wall is peptidoglycan (PG).  Gram-
positive bacteria have a thicker cell wall, 15-18 nanometers (nm), composed of many 
layers of PG, as opposed to Gram-negative bacteria, 10 nm with one layer of PG.  Gram-
negative bacteria have the outer membrane, which often contains lipopolysaccharide 
(LPS or endotoxin), and is generally toxic to the host. Peptidoglycan is the main and 
strongly immunogenic component of a gram-positive bacterias cell wall (Krause and 
McCarty, 1961; Heymer et al, 1985; Rosenthal and Dziarski, 1994), just as is LPS on the 
Gram-negative bacteria.   
Peptidoglycan (synonyms: glycopeptide, mucopeptide, or murein) is a 
heteropolymer consisting of a polysaccharide backbone forming glycan strand, composed 
of β(1-4)-glycosidically linked N-acetylglucosamine  (NAG) residues.  Each alternate N-
acetylglucosamine residue is substituted by D-lactic acid ether in cis C-3 hydroxyl group.  
This derivative of glucosamine is called muramic acid (NAM, Heyman et al, 1964).  The 
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carboxyl group of NAM is substituted by an oligopeptide which contains alternating L- 
and D- amino acids.  Adjacent peptide subunits are cross-linked either directly or via an 
inter peptide bridge.  This gives rise to a large macromolecule encompassing the bacterial 
cell.  The glycan strand of various peptidoglycans is rather uniform, but different amino 
acid sequences can be found in PG of various bacteria.  In most cases, L-alanine is bound 
to muramic acid, followed by D-glutamic acid, a diamino acid L-Lysine and D-alanine.  
However, in some species of Staphylocci (i.e. S. aureus) and some Strep, an additional D-
alanine is found at the C-terminus (Schleifer and Seidl, 1974).  Other important cell-wall 
components besides the PG include the group-specific carbohydrate hapten, which 
contains rhamnose and NAG, and are referred to as polysaccharide (PS). Often, 
complexes of peptidoglycan (PG) and polysaccharides (PS) are isolated from gram-
positive bacteria and used as antigen in different animal models.  These complexes are 
referred to as PG-PS.  
B. Clinical Manifestations of Bacterial Infection 
Infection of a host with Gram-positive or Gram-negative bacteria results in 
similar clinical manifestations, such as inflammation, fever, leukocytosis, hypotension, 
decreased peripheral perfusion, malaise, decreased appetite, sleepiness, and arthritis 
(Wang et al, 2000).  These symptoms are caused by mediators released from host cells 
that were exposed to the bacterial cells and their components (Wang et al., 2000).  The 
main parts of bacteria responsible for these clinical manifestations are endotoxins and 
peptidoglycans (Dziarski, 1980).  
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C. Immunochemistry of Peptidoglycan 
From the experiments of Abdula and Schwab (1965), and Karakawa et al. (1966, 
1967, 1968) it was determined that it was possible to obtain anti-PG sera from rabbits that 
were immunized intradermally or intravenously with PG.  However, the antibody 
response was never as marked as when the vaccine was prepared from the heat-killed 
whole cells of gram-positive cocci.  There have been at least five different antigenic 
epitopes of PG described:  epitope a - the glycan strand, epitope b  N-terminal, epitope c 
c-terminal of interpeptide bridge, epitope d  the uncrossed peptide subunit tetrapeptide, 
and epitope e - peptide subunit pentapeptide (Karakawa et al. 1967; Rolička and Park, 
1969).     
The main target cells in a host responding to endotoxin and peptidoglycan are the 
monocytes and macrophages, activated through two pattern recognition receptors CD14 
and Toll-like receptors (TLRs) (Dziarski et al 1998, Poltorak et al 1998; Yoshimura et a, 
1999; Schwandner et al 1999).  The main proinflammatory mediators induced by immune 
cells of host by endotoxins and peptidoglycans are the cytokines TNF-α, IL-1, and IL-6.  
Wang et al. (2000) challenged this hypothesis and found that over 120 genes were 
activated in human monocytes by S. aureus, peptidoglycan, and endotoxin.  All three 
bacterial stimulants induced gene transcription predominantly for chemokine IL-8, and 
macrophage inflammatory protein (MIP-1α), while cytokine genes (TNF-α, IL-1, and IL-
6) were induced to a lower extent.  The gene expression was evaluated using cDNA 
arrays, confirmed by quantitative RNase protection assay and high secretion of 
chemokines was confirmed by enzyme-linked immunosorbent assays.  Peptidoglycan 
also induced other chemokines like MIP-2α, MIP-1β, and monocyte chemoatractant 
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protein-1 (MCP-1) in higher amounts than cytokines.  Gold et al. (1985) showed that 
when β-lactam antibiotics are administered to humans with Strep infection, soluble non-
cross-linked PG polymers are released by cocci, which results in IL-1-mediated 
inflammatory reaction.  
VI. Pregnancy Loss Due to Endotoxin and Peptidoglycan 
 It has been known that animals show greater susceptibility to bacterial pathogens 
during pregnancy (Apitz et al., 1935).   
A. Endotoxins and Pregnancy Loss 
 Experimentally induced endotoxin infection can lead to abortion and death of the 
dam (Zahl, 1943; Rieder, 1960; Chedid, 1962).  According to Giri et al. (1991) endotoxin 
from Gram negative bacteria have two main physiological effects:  First, endotoxin 
causes regression of the CL which is often linked to abortion in many species like mice, 
goats, pigs, mares and cows (Skarnes and Harper,1972; Rious-Darrieulat, 1978; Wrathall 
et al., 1978; Fredricksson et al., 1985; Fredricksson et al., 1986; Giri et al.1990).  Second, 
endotoxin produces metabolic, circulatory, hematological and reproductive disturbances 
partly via release of prostaglandins, thromboxane, leukotriens, and cytokines (Anderson 
et al., 1975a, b; Fletcher and Ramwell, 1977; Morrison and Kleine 1977; Jesmok and 
Borgia, 1985; Lang et al. 1985, Cort and Kindahl, 1990; Trebichavský et al., 2002).  
Chaoaut at al. (1990) showed that LPS led to release of TNF-α, leading to dose-
dependent enhancement of embryo resorptions up to 100 %.  The same group (Chaoaut at 
al., 1990) also examined the effect of injecting various cytokines directly to pregnant 
mice.  They found that 1000 units of TNF-α enhanced resorptions from 43 to 79% in 
CBA x DBA/2  abortion-prone mice, and from 7% to 89% in non-abortion prone mice.  
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Gamma interferon and recombinant interleukin 2 (IL-2) also enhanced resorptions from 
38 to 68% and to 76% and from 6 to 44% and 55 % in four different mating 
combinations, in abortion prone and non-abortion-prone mice, respectively.  On the 
other hand, cytokines such as IL-3 and GM-CSF, belonging to CSF family, increased the 
chances of fetal survival and reduced resorptions in the abortion-prone CBA/J x DBA/2 
mating combination from 55% to 22 % (IL-3) and 47 to 8 % (GM-CSF).  These results 
indicate that balance of inflammatory and anti- inflammatory cytokines is involved in 
mediation of embryonic resorption and survival, and that the deleterious effect of 
inflammatory cytokines on pregnancy can be prevented.  
Skarnes and Harper (1972) provided direct evidence for synthesis of 
prostaglandin F in mouse uterine endometrium as a result of parenteral administration of 
bacterial endotoxin and concluded that abortifacient action of endotoxin is mediated by 
PGF2α.  A single injection of 5 µg of endotoxin on day 16 of gestation caused maternal 
diarrhea and intrauterine fetal death. Higher doses (10, 20 µg) caused abortion. 
Interestingly, the same group found high amounts of PGF or its metabolites in the urine 
of males as well as pregnant female mice.  Hence, they suggested that endotoxemia 
evokes a generalized, not local synthesis of F-prostaglandins.  Skarnes and Harper (1972) 
proposed that prostaglandins were working indirectly through other substances, like 
serotonin.  Serotonin is a lipid insoluble amine that functions as both a neurotransmitter 
and an endocrine hormone regulating gastric secretion and smooth muscle contraction in 
blood vessels (Randal et al, 1997).  Administration of serotonin antagonist helped to 
lessen the abortion-causing action of endotoxin (Skarnes and Harper, 1972).  Cseply and 
Csapo, as well as Wiqvist et al. (1972) proposed that PGF2α acted as a strong 
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vasoconstrictor and as smooth muscle constrictor, which contributes to its abortifacient 
action by decreasing the blood flow to uterus and by premature contractions of uterus.  
B.  Peptidoglycan and Pregnancy Loss 
 Peptidoglycan-polysaccharide complex (PG-PS) makes the structural support of 
the cell wall of Gram-positive bacteria.  Bacteria lysed in the host release this compound 
and thus elicit an immune response, which has been found to be detrimental to pregnancy 
maintenance in sheep (Barker 1999), and humans (Gibbs and Blanco, 1981).  Women 
infected with aerobic Strep of Group A, B, D, Strep pneumonidae or viridans streptococci 
had either endometriosis (inflammation of uterus) or chorioamnionitis (inflammation of 
chorioamnion) with early onset of fever as the main clinical presentation (Gibbs and 
Blanco 1981).  Fortunato et al. (1998) stimulated cultured human amniochorion from 
uncomplicated gestations with PG-PS from Group A lytic Strep and found significant 
increases of IL-6 and IL-8, both mRNA expression and protein. However, IL-6 and IL-8 
release response was found much greater with LPS challenge (Fortunato et al. 1998).  
Some suggested that abnormal colonization of bacteria in the genital tract increases 
prostaglandin synthesis, which initiates labor in humans (Bennet et al, 1987; Lamont et 
al, 1990; Reisenberger et al., 1997), however, others suggest that the early onset of labor 
is not caused by mere presence of bacteria, but by the endogeneous host mediated 
mechanism involving inflammatory cytokines (Romero et al., 1989; Mitchell at al., 1990, 





VII. Vaccination with Peptidoglycan-Polysaccharide Complex: Possible Prevention 
of Early Embryonic Loss and Mastitis 
 A.  Principles of Vaccination 
Vaccination by definition is the deliberate induction of adaptive immunity to a 
pathogen by injecting a vaccine, which is a dead or attenuated form of the pathogen 
(Janeway et al., 2001, p.706). Edward Jenner, in 18th century, was the first to use 
vaccinia.  He injected a cowpox virus in a young boy, which lead to immunity to the 
human smallpox virus (Janeway et al., 2001, p.1). Vaccination causes naïve lymphocytes 
to proliferate and differentiate into effector cells and memory cells (Sprent and Tough, 
1994).  The cellular and molecular events that occur after successful primary vaccination 
depend on the type of organism in question, bacterial, viral, parasitic, or fungi, and its 
favorite environment in the host  extracellular (interstitial spaces, blood, lymph, or 
epithelial surfaces) versus intracellular (cytoplasmic or vesicular, Janeway et al., 2001, 
p.386).  The type of organism and location of infection determine the type of the immune 
response.  Immune responses can be humoral by the generation of protective antibodies 
(immunoglobulin (Ig) G, IgA, IgE) or cellular by the activation of CD4 T cells (Th1, 
Th2, supressor, or CD8 CTL).  The cascade of events initiated after inoculation with an 
antigen includes inflammatory response and activation of innate immunity; activation of 
specialized antigen presenting cells; antigen presentation to lymphocytes in peripheral 
lymphoid organs; activation and signaling through the lymphocyte receptors; clonal 
expansion of lymphocytes and generation of effector cells; destruction of antigen; and 
generation of immunological memory.    
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It is the immunological memory that enables successful vaccination and prevents 
reinfection with pathogens that have been repelled successfully by an adaptive immune 
response.  Immunological memory is the most important biological consequence of the 
development of adaptive immunity, although its cellular and molecular basis is still not 
fully understood.  At the lack of antigen, B cell proliferation and hypermutation stops.  
As well, the B-T cell interaction will be terminated, and the effector cells die out.  Only a 
relatively small subset forming the memory cells will remain to serve quickly in future 
antigen exposure. Recent suggestion of Callan and coworkers (2000) is that memory cells 
have different clonotype than the primary effector cells, which are predestined to die by 
apoptosis after depletion of the antigen.  
B. Gram-Negative Vaccines       
    
Rioux-Darrieulat (1978) prevented abortion induced by endotoxin, using antisera 
to endotoxin, raised in different animals.  This form of passive immunization protected 
pregnant mice even more effectively, when both antiserum and antiserotonin were used. 
A summary of investigation of immunization and immunotherapy for mastitis during the 
eighties and early nineties (Tyler et al. 1993) led to development of vaccines for gram-
negative mastitis, but development of vaccines for other mastitic pathogens has been 
slower.  Vaccine to coliform mastitis J5 has been developed and tested.  Hogan et al. 
(1999) reported that heifers immunized with E. coli J5 bacterin subcutaneously 60 and 32 
days before calving, and then again within 48 hours after calving, had reduced severity 
and local signs of clinical mastitis, after being challenged with E. coli via intramammary 
infusion one month after calving.  (This report seems to be misleading, because the data 
do not appear to support the conclusion that the vaccine was effective. Perhaps the choice 
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of statistical procedure to analyze the results was not appropriate.)  Profitability of using 
J5 vaccine was evaluated by DeGraves and Fetrow (1991).  They enumerated that it was 
profitable to use J5 vaccine if 1% or more of cow lactations resulted in clinical coliform 
mastitis.  
C. Gram-Positive Vaccines 
Preventive herd management practices that include dry cow therapy, segregation 
of sick and healthy cows, and selective culling have helped to decrease mastitis 
prevalence.  However, S. aureus is still a major problem on many farms (Sears, 2002).  S. 
uberis, as one of the major environmental pathogens, is also problematic since it is 
ubiquitous in the dairy environment and is associated with sub-clinical mastitis. 
Development of effective Gram-possitive bacterial vaccines could greatly enhance milk 
production and reproductive performance as well. 
Schleifer and Seidl (1974) synthesized a C-terminal D-alanyl-D-alanine 
pentapeptide (Glycine-L-Alanine-L-Alanine-D-Alanyl-L-Alanine) component of 
bacterial PG and rendered it immunogenic by coupling it to a carrier protein human 
serum albumin.  Immunization of rabbits with this conjugate lead to generation of 
antisera and, these antibodies showed cross-reaction with solubilized peptidoglycan 
carrying the same pentapeptide and with another conjugate with similar, but different, 
pentapeptide.  This indicated that these three antigens (whole and two different PG and 
pentapeptide) had identical determinant groups with respect to the antisera employed. 
Daily pretreatment of rabbits with small doses of peptidoglycan induced tolerance to the 
pyrogenic effect (Lavický et al., 1988).   
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Reports of vaccination of dairy cows against environmental pathogens such as 
Strep uberis and Strep dysgalactiae are limited (Potter, 2002). Current research is 
oriented towards identification of conserved potential virulent factors on the bacterial cell 
surface as targets for vaccines (Song et al., 2001; Potter, 2002).  Vaccination with live 
Strep uberis, and soluble surface extract derived from the same bacteria did result in 
protection against experimental challenge (Hill et al., 1994), but it was less effective 
against heterologous strains of Strep uberis (Finch et al., 1997).  Killed Strep uberis 
administered repeatedly also provided some protection against subsequent challenge, 
however, that treatment did not reduce inflammation of the mammary gland (Finch, 
1994).  Recently, vaccination with a concentrated Strep uberis culture supernatant, 
containing PauA, a plasminogen activating protein produced by this pathogen has been 
used by Leigh et al., (1999, 2000).  PauA was proposed to be one of the determinants of 
Strep uberis aiding in dissemination of the bacteria into tissues at the site of infection 
(Leigh, 1994; Rosey et al., 1999).  Subcutaneous vaccination resulted in 37.5 to 62.5 % 
protection from clinical mastitis after challenge with heterogous strain (Leigh et al, 
1999).   
Potter (2002) focused on development of vaccines to Strep uberis and Strep 
agalactiae using recombinant GapC (6xHis), Mig, and CAMP factors. GapC is the 
bacterial surface-associated glyceraldehydes-3-phospate dehydrogenase capable of 
providing broad spectrum protection (Potter, 2002). The mig gene of Strep dysgalactiae 
encodes two Mig protein-binding receptors, α2-macroglobulin (α2-M) and 
immunoglobulin G (IgG), and it was speculated that binding of bacterial Mig proteins to 
plasma protein α2-M or IgG in a host prevents phagocytosis by bovine neutrophils (Song 
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et al., 2001). Song et al. (2002) also found that Mig protein of Strep dysgalactiae bound 
bovine immunoglobulin A (IgA).  IgA binding proteins seem to represent bacterial 
protection against phagocytosis, because the binding of human IgA to receptors in Strep 
pyogenes has been found to interfere with bacterial adhesion to the host cells (Fluckiger 
et al., 1998).  Vaccination with recombinant Strep uberis GapC or CAMP-3 resulted in 
significant reduction in inflammation of cows mammary glands several days post-
challenge, especially for Strep uberis. Inflammation was not reduced in Strep 
dysgalactiae vaccinates, suggesting lack of cross-species protection (Fontaine et al. 
2002).  
VIII. Summary 
Mastitis is an unresolved problem in the dairy industry.  Main components, PG-
PS and LPS, of the bacteria involved in mastitis cause an array of biological disturbances 
in the host, including negative effect on embryo /fetus survival.  A partial solution to this 
problem could be to administer agents that prevent the action of inflammatory mediators 
or drugs that kill bacteria.  Prevention of mastitis via management practices and 
immunization against mastitis would be more economical and effective and should result 
in protection of early pregnancy.  The aim of this study was to find out if immunization 
with bacterial peptidoglycan can lessen the negative impact of bacterial challenge soon 





   The primary goal of this study was to induce the protective immune mechanism 
by repeated inoculation of ewe lambs with PG-PS or the whole killed bacteria of Strep 
pyogenes.  The experimental hypothesis was that the immunization will enhance early 
pregnancy maintenance in ewe lambs which are exposed to pathogen shortly after 
breeding.  Similarly it was hypothesized that immunization with PG-PS  and/or with 
killed cells will decrease occurrence of mastitis during the first lactation in ewe lambs.   
The secondary goal was to compare effects of whole heat killed cells of Strep 
pyogenes and PG-PS isolated from Strep pyogenes on two characteristics, pregnancy and 
mastitis.  The associated experimental hypothesis was that the PG-PS and whole killed 
cells elicit different response in terms of pregnancy maintenance and mastitis.  If the 
effect will not be different and both preparations are beneficial for animals used, the 
whole cells will be easier to obtain.   
Ewe lambs have the advantage of lower cost and shorter gestation than dairy 








MATERIALS AND METHODS 
I. Bacteria Growth and Peptidoglycan-Polysaccharide Isolation  
Peptidoglycan-polysaccharide-complex was isolated from Strep pyogenes as 
summarized by Stetson and Dziarski (1994), except for modification of Wells et al. 
(1986) which did not include removal of the teichoic acid and carbohydrates.  Therefore, 
the name of the product was peptidoglycan-polysaccharide complex (PG-PS).  This 
product closely resembled the commercially available PG-PS 100P (Lee Laboratories, 
Grayson, GA, product # 210868) as assessed by Barker (1999).    
 Aseptic techniques were used following the Biosafety Level 2 standard and 
special practices and regulations (HHS, Center for Disease Control 93-8395).  All the 
manipulations with cultures were performed in a laminar flow hood with UV light 
decontamination.  The solutions were sterilized before use.  The chlorine solution was 
poured into the waste media after filtration, and all waste and utensils were sterilized by 
autoclaving. 
(i)  Growing and harvesting the bacterial cells:  Freeze-dried specimen of Strep pyogenes 
group A, type 3 (American Type Culture Collection, (ATCC), 10389) was rehydrated 
with 5 - 6 ml of Brain Heart Infusion (gift from Dr. M. Elliott, Department of 
Immunology and Microbiology, West Virginia University) according to ATCC 
propagation procedure and used to inoculate Trypticase Soy Agar (TCA) with 5% 
defibrinated sheep blood (Fisher, B21239X). Plates were incubated at 37ûC for 48 hours; 
the rest of the revived culture was divided into aliquots of 2 mL volume (1.7 mL of Strep 
pyogenes culture plus 0.3mL of sterile glycerol) and frozen at - 80ûC.  The colonies of 
Strep pyogenes were identified on the agar plates as entire, glistening, circular, smooth, 
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small, and by almost translucent agar in immediate vicinity of growth due to lysis of red 
blood cells (Girard, 2000).  The isolated colony was used to inoculate 10 ml of sterilized 
Todd Hewit Broth (THB) (Fisher, DF0492-17-6), and incubated in loosely capped glass 
tubes over-night at 37ûC.  After 24 hours, the content were transferred into 100 mL 
bottles with screw caps containing sterilized THB using 1:10 dilutions, and left in 
incubator at 37ûC overnight.  The glass bottles with sterilized, 900 mL of THB were 
inoculated after 24 hours with the bacterial content of 100 mL tubes and left in incubator 
at 37ûC for 24 hours again.   
 Bacteria were captured by filtration using sterile disposable 500 ml bottle-top 
filters with PES membrane (Nalgene, HX8199H, pore size 0.45 µm) using vacuum 
pumps.  One filter was used for one liter of media with bacteria.  Bacteria were washed 
on filters once with 50 mL of sterile phosphate buffered saline (PBS, 0.1M NaH2PO4 and 
0.15 M NaCl, pH 5.3) and harvested by scrapping with a sterile metal spatula, put in 
tubes, weighed and washed two more times with 50 mL PBS, followed by centrifugation 
at 2,500-x g for 20 min at 4ûC and removal of supernatant.  Tubes with cells and 
supernatant from last wash were stored in refrigerator until sonication.  The average yield 
from 1 L of media was 1.18 g wet bacterial cells.  Bacterial growth was carried out in 
batches of about 10-12 liters. After 13 batches, 134 g of wet cells were produced.   
(ii) Rupturing the cells by sonic treatment: The supernatant from the last centrifugation 
was gently removed.  Cells were pooled and resuspended in PBS (approximately 50 g 
wet weight in 180-200 mL PBS).  Suspensions were sampled for Gram-staining (Gram 
Stain Set, Fisher, 2300583).  Weight of wet cells in pooled suspension prepared for 
sonication was recorded. The suspension was sonicated in 70 ml batches for 90 minutes 
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(Heat System Ultrasonics, Inc.: Long Island, NY, used the middle probe and amplitude 
5). The sonication was done in the hood, and the vessel with cell suspension was partially 
submerged in the ice water bath, adding the ice frequently.  During sonication, the 
suspension was covered by aluminum foil and gauze soaked in 70 % alcohol to ensure 
sterility.  
The ultrasonic liquid processor converts electrical energy to mechanical vibration. 
This causes cavitations in the liquid sample such that microscopic vapor bubbles are 
formed momentarily and implode, breaking cells or tissue by powerful shock waves.  
After sonication, suspension was transferred to sterile tubes and centrifuged for 30 
min at 10,000 x g, at 4ûC.  The supernatant, containing the cell wall fragments, was 
aspirated with a sterile Pasteur pipette, and stored in sterile containers.  Pellets were 
weighed, resuspended, pooled, sonicated, and centrifuged again, until the pellet was less 
than 20% of the original wet weight.  Total sonication time for 134 g of cells was 54 
hours.  Success of the sonication treatment was checked by Gram-staining of samples 
from the supernatants.  Gram-stain principle is differential retention of dye in the two 
main classes of bacteria.  To perform the procedure, cells were stained with crystal violet 
and added iodine.  The slide was decolorized with alcohol/acetone and counterstained 
with safranin or basic fuchsin.  Crystal violet forms a complex with iodine in the 
protoplast of organism/cell, recognized microscopically as dark purple.  Organisms that 
retain the dye after decolorization with alcohol are classified as Gram-positive, and those 
that are decolorized when counterstained are Gram-negative.  Bacteria containing 
lipopolysacharides have higher lipid content in their cell envelopes compared to other 
bacteria, which makes them more permeable to alcohol, thus the dye is washed away.  
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When the Gram-positive cell walls are fractionated after sonication, the cells are unable 
to retain the dye, thus they behave as Gram-negative.  This is what was observed.  
Sterility of the cell wall fragments was confirmed by culturing 0.1 mL on sheep blood 
agar (Sartor et al. 1985). 
(iii) Purification of the PG-PS:  To remove the cell constituents, pooled supernatants 
were treated sequentially by different enzymes (Sigma, St. Louis, MO) in dialysis tubing.  
a) hyaluronidase (H6254 Type V) in 0.1 M phosphate/0.15 M NaCl (pH 5.3);  
b) deoxyribonuclease (D5025; 375,000 units) and ribonuclease (R5000, Type II-A) 
       in 0.1 M phosphate buffer (pH 7.2);  
c) papain (P4762) in 0.1 M phosphate  buffer (pH 7.2) containing 0.001 M cysteine 
(C8882), 0.001 M  EDTA and 0.05 % sodium azide, and 
d) pepsin (P6887)in 0.012 N HCl (pH 2); 
The amount of 1.24 mg of deoxyribonuclease and 0.0025 mg of all other enzymes per mg 
wet weight of cells was used. Dialysis tubing (110 mm wide) was cut to 10 inches length 
and softened by boiling in 2 % sodium bicarbonate and 1 mM EDTA solution for 10 
minutes, rinsed in deionized water, boiled in deionized water for 10 minutes, and then 
rinsed and stored at 4ûC while submerged in deionized water until used.  The dialysis 
bags were filled with the cell wall fragments (CWF) suspension, clamped with closures 
(Fisher, Spectra/Por Nylon, 0867154) and placed in a large beaker containing appropriate 
buffer with a few drops of chloroform (Sigma, C5312) for 12 hours 4ûC.  The next day, 
hyluronidase was added to CWF, while dialyzing for six hours on a hot plate (37ûC) 
using a stir bar and changing the buffer every two hours.  After six hours, the appropriate 
buffer for the next enzymatic digestion was poured in to the beaker for overnight dialysis 
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with few drops of chloroform, and the process was repeated.  Enzyme digestions were 
during the day and buffers were changed overnight at 4ûC.  For each enzyme, quality 
control needed to be carried out, using hyaluronic acid, DNA, RNA, hemoglobin, and 
homogenized animal tissue (chicken meat was used) as substrates for enzymes 
hyaluronidase, deoxyribonuclease, ribonuclease, papain, and pepsin, respectively.  The 
CWF was collected and washed by repeated centrifugation at 100,000 g 
(ultracentrifugation), keeping the pellet. Thus the technical name of the final product is 
PG-PS 100P (Lee Laboratories, 1997). The pellets were resusupended in 0.1 M 
phosphate buffer and ultracentrifuged, the process was repeated two more times.  The 
final pellets were resuspended in 200 mL of sterile water, put in dialysis bags and 
dialyzed against water at 4ûC for 12 hours.  
Chloroform:methanol lipid extraction took place at room temperature.  Dialysis 
bags were opened in 1000 ml beakers, and volume of CWF in water was measured in a 
graduated cylinder.  Chloroform : methanol (CM) (Sigma, C5312, M1775, respectively) 
mixture (2:1) was added to the CWF water suspension such that the final ratio of CM to 
CWF was 5:1 and stirred for two hours.  After letting the CM : CWF in water suspension 
sit for awhile, the phases visibly separated. The chloroform phase with the lipid, the 
bottom phase, was aspirated with a sterile pipette connected to a vacuum pump.  The 
volume of methanol with sample was measured.  After subtracting the initial volume of 
the sample, the volume of methanol was determined.  Chloroform was added to methanol 
with sample to keep the 2 to 1 chloroform : methanol ratio and then more CM was added 
to equal the initial extraction volume.  The process was repeated twice.  The water phase 
with CWF was then dialyzed against water, changing the water three times during twelve 
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hours.  The product was then poured from dialysis bags into a pan, shell frozen with dry 
ice and 2-propanol, covered with sterile gauze and lyophilized for about 20 hours to 
ensure adequate drying.  Dried PG-PS was white, thin aggregates.  The original 134 g of 
wet cells of Strep pyogenes produced 0.88 g of PG-PS, which means that 1 gram of wet 
cells yielded 0.0065 g of PG-PS.   
(iv) PG-PS product analysis: The amount of methylpentose molecules in PG-PS was 
determined by the rhamnose assay described by Dische and Shettles (1948).  Rhamnose 
(R3875) and cysteine hydrochloride (C6852) were purchased (Sigma, St. Louis, MO), 
and commercial PG-PS was purchased (Lee Laboratories).  Prepared solutions were: 2 
mL of rhamnose standard solution with concentration 0.005 g/mL of water; 250 µL of 
PG-PS solution (0.00008 g /µl); 117 mL of sulfuric acid solution (16.71 mL of water and 
100.28 mL of sulfuric acid); and 2.6 mL of 3% cysteine hydrochloride.  Water was added 
to twelve pairs of tubes with 200, 150, 100, 50, 20, 10, and 5 µL of rhamnose solution 
and 50, 25, 12, 8, and 5 µL of PG-PS sample solution, and to two empty (blank) tubes, to 
bring the volume to 1 mL in each.  Then, to all tubes in cooling ice, 4.5 mL of 
water/sulfuric acid was added.  The mixture was then warmed to 20 to 22ûC for few 
minutes, held in an actively boiling water bath for 10 minutes, and then cooled in tap 
water.  When cool, 0.1 mL of 3% aqueous cysteine hydrochloride solution was added to 
each tube and shaked.  Reaction of this mixture gave a greenish yellow color. The 
absorbance was measured via a spectrophotometer (Beckman DU-600).  A standard 
curve was developed from known rhamnose concentrations, using linear fit (Absorbance 
= 0.15414 + 0.00421 x Concentration) of version 3.0 of JMP (SAS Institute, Cary, NC) 
statistical software.  The concentration of rhamnose in the PG-PS product was estimated, 
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adjusted for volume of PG-PS solution in each tube and averaged.  Two readings that 
exceeded the linearity of the spectrophotometer (> 3) were excluded.  The average 
rhamnose concentration was 0.51 mg in 1mg of PG-PS (51 %).   
(v) Determining the dosages of PG-PS:  Concentration of 51 % of rhamnose in isolated 
PG-PS corresponds to the PG content (Lichtman et al., 1993).  One g of the wet cells of 
Strep pyogenes had 0.0033g of PG.  Barker (1999) showed marked pregnancy reduction 
with 60 µg PG/kg body weight (bw).  Therefore, that dose was chosen to be the challenge 
injection and 30 µg PG/kg bw to be an initial and booster injection.  We had 0.51g PG in 
1 g of PG-PS product, (1÷0.51=1.96).  To attain 30 µg PG/kg bw for first two injections, 
58.82µg of PG-PS (30 x 1.96) was required per kg.  Considering average weight of ewes 
to be 50 kg, approximately 3 mg of PG-PS per ewe and 150 mg for 50 ewes was 
suspended in 150 mL of sterilized 0.9 % sodium chloride solution.  Prior to injection, 
product was sonicated for 90 min to ensure the solubility and prevent the aggregation of 
PG-PS molecules.  The dose for one ewe was 3 mL of suspension.  Dose for the 
challenge injection (60µg PG/kg bw) was calculated the same way. 
II.  Preparation of Whole Killed Cells 
 Strep pyogenes were grown in three batches as described earlier, producing 27 g 
of wet cells.  Prior to harvesting the cells, the flasks with bacteria in media were 
submerged into 60 ºC water bath for one hour to kill bacteria by pasteurization.  Then, the 
cells were harvested by filtration as before and washed and spun 4 times using 
centrifugation (Sorvall ®Super T21, 5000 x g, 30 min, 4ºC) and 0.9 % sterile sodium 
chloride (saline). The supernatant was discarded.  After the last wash, cells were 
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suspended in sterile saline (14 mL for each g of wet cells).  The suspension was divided 
into aliquots and frozen until required.  
The dose of killed cells was determined via the approximate PG-PS content in 
whole cells based on rhamnose assay.  Approximately 0.0065 g of PG-PS was in 1 g of 
wet cells.  To ensure 30 µg PG/kg/bw, 0.00003 g divided by 0.0065 is 0.00461 g of cells 
per kg, which means 0.23 g of wet cells per 50 kg ewe, suspended in 3 mL of sterile 
saline.  The dose of whole killed cells preparation for immunization injection was based 
on the PG-PS instead on PG (30 µg PG-PS/kg/bw, instead of 30 µg PG/kg/bw).  
III.  Assignment of Treatments  
A total of 200 Rambouillet ewe lambs were assigned at random into 4 treatment 
groups (n = 50 per group).   
• Group 1 (G1, Immunized with PG-PS) sheep were immunized by subcutaneous 
administration of a preparation of PG-PS (30 µg PG /kg body weight (bw)) on day 0 
early in October 2000.  A second (booster) injection of PG (30 µg/kg bw) was given on 
day 22.  At day 36, estrus was synchronized,  and ewes were bred to rams at estrus 
around day 42.  On day 5 after breeding (~ day 47 from first inoculation), ewes were 
injected with a higher dosage of PG-PS (60 µg PG/kg bw) via jugular vein.   
The final injection on day 5 after breeding is served to mimic the real bacterial 
challenge, imitating infection and inflammation such as mastitis.  Therefore, for the rest 
of this document, the last injection is referred to as a challenge.  
• Group 2 (G2, Immunized with killed cells) ewes were immunized 
subcutaneously at day 0 and day 22 with heat killed bacterial cells, then had estrus 
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synchronized on day 36, and were observed for estrus and bred.  On day 5 after breeding 
(~ day 47), ewes were challenged with intra-venous injection of PG-PS (60 µg PG/kg 
bw).   
• Group 3 (G3, Not immunized, challenged) ewes received the physiological 
solution-saline at the time of first two injections as G1 and G2, then were synchronized, 
observed for estrus, bred and challenged with the same dose of PG-PS (60 µg PG/kg bw) 
as G1 and G2 ewes on day 5 after breeding.  
• Group 4 (G4, Saline), as a control group, received only saline at day 0, 22 and 47.  
Blood samples were collected from the jugular vein every two weeks, from day 0 
until day 84.   
An additional 35 mixed breed ewes were randomly divided into 4 groups and were 
treated as above.  In this group, blood samples were taken once every week from day 0 
and daily after challenge (day 5 after breeding) until day 42 of pregnancy (day 84 from 
initial inoculation).  For the first 6 hours after challenge, blood samples were taken every 
15 minutes and then every day until pregnancy check (d 42).  The body temperature was 
monitored in the group of 35 ewes for 12 hours after each injection (day 0, 22 and 47) 
and then 24 hours post injection.  
IV.  Animals 
Experimental animals were ewe lambs born in Fall 1999 to March 2000.  At the 
USDA Sheep Experiment Station in Idaho 200 Rambouillet sheep were on the ranch 
from early spring to late summer and then housed in pens of about 50 ewes outside.  Of 
200 Rambouillet ewes initially treated, 160 responded to estrous synchronization, thus 
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were bred and challenged with PG-PS or killed cells or treated with saline.  The second 
group was 35 mixed breed Dorset and Suffolk ewes at the West Virginia Agriculture and 
Forestry Experiment Station Animal Science farm in Morgantown, housed in a three-
sided barn with expanded mesh metal flooring.  Of 35 mixed breed ewes 32 responded to 
estrous synchronization and were bred and challenged.  All procedures were approved by 
West Virginia University Animal Care and Use Committee (ACUC #9801-06).  Estrous 
behavior of ewes in the presence of vasectomized rams was observed prior to beginning 
the experiment in the Fall 2000.  Vaginal progesterone pessaries (MAP, Canada) were 
inserted into the ewes, and the vasectomized rams were removed from the group.  Five 
days later, ewes received one intramuscular injection of prostaglandin F2α (3 mL, 5 
mg/mL; Lutalyse; Pharmacia and Upjohn, Inc. Kalamazoo, MI).  After another 5 days, 
pessaries were removed, and ewes received an injection (5 mL im) of commercial 
gonadotropins (PG-720-1, Intrervet, Charlotte, NC).  The majority of ewes were in estrus 
within 48 hours.  Fertile rams with chest markers were put in pens with ewes at the ratio 
of one ram per ten ewes.   
V.   Collection of Data on Pregnancy and Mastitis  
 Pregnancy status was examined in all ewes on day 42-post breeding by transrectal 
ultrasonography (Schrick et al. 1993), using an Aloka 500 console with a 7.5 MHz linear 
transducer designed for examination of the human prostate (Corometrics Medical 
Systems, Wallingford, CT).  The age of an embryo was based upon size.  Pregnancy data 
were confirmed by another pregnancy diagnostics at day 60 of gestation using the sector 
scanner.  
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Milk samples were collected from mixed breed ewes (N=35) in the middle and at 
the end of lactation (39 and 98 days post partum, respectively) by a described procedures 
(Keisler et al. 1992, Fernández-Garayzábal, 1998).  The first 5 mL of milk from each half 
of each ewes udder was discarded.  Teat ends were cleansed with gauze moistened in 
70% ethanol, and about 5 mL was collected directly on to the California Mastitis Test 
plates and evaluated according to manufacturers instructions.  Additionally, 5 mL of 
milk was collected directly into a sterile tube without touching it and placed on ice.  
Within 2 hours of collection, 0.01 ml of milk was transferred using disposable 
bacteriological eye loops onto Petri plates containing Trypticase Soy Agar (TCA) with 
5% defibrinated sheep blood (Fisher, B21239X).  Plates were incubated at 37 ºC for 48 
hours before examination for microbial growth.  Determinations were made on the basis 
of colony morphology and Gram-staining  (Schneierson, 1965).  
Mastitis could not be evaluated in Rambouillet ewes due to an unexpected 
disease.  A Camplylobacter infection that resulted in 65 % of late abortions or early death 
after birth affected most of the animals at the sheep experiment station.   
VI.  Assays of Antibody 
      Activation of humoral immunity by vaccination was determined by measuring the 
IgG antibodies to PG-PS in serum.  Enzyme-linked immuno-sorbent assay (ELISA) 
protocol was adapted from Barker et al. (1998) and Yamamoto et al. (1996).  
Flat bottom ELISA plates (96WL Easywash, HB, 07-200-642, Fisher Scientific) 
were coated with 100 µL/well of sonicated PG-PS solution (0.002 µg PG/µL phosphate 
buffered saline (PBS) = 2µg/mL in PBS with 0.04 % sodium azide) and were covered and 
left overnight at 4 °C.  Plates were washed four times with PBST (PBS +0.5 % Tween 
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20, no sodium azide in a wash buffer), using an automated washer and then 200 µL/well 
of blocking agent PBSTG (50 µl Tween 20 and 0.5 g porcine gelatin in 100 mL of PBS, 
stirred and heated at 37°C for 10 min) was added and left overnight at 4 °C.  Fresh 
PBSTG was prepared every time before each use, as it gelatinizes in the refrigerator. 
Therefore, before the next wash, plates were left at room temperature for an hour for 
gelatin to soften.  Plates were washed four times with PBST, and 100 µg/well of primary 
antibody sheep plasma samples gradually diluted in PBSTG were added and incubated 
overnight at 4 °C.  Plates again were washed four times with PBST, and 100 µl/well of 
secondary antibody - alkaline phosphatase conjugated rabbit antisheep IgG (H+I) diluted 
1: 3000 in PBSTG (RBT anti-sheep IgG AP OB6159-04 Fisher Scientific) was added and 
incubated at 37 °C for 1 hour.  Plates were washed six times with PBST.  The enzyme 
substrate P-nitrophenyl phosphate (1 mol/L diethanolamine was added with 0.5 mmol 
MgCl2 pH 9.8, OB201-01, Fisher Scientific) was disolved in substrate buffer (24.5 mg 
MgCl2.6H2O and 48 ml diethanolamine add to 400 mL double distilled H2O, adjusted to 
pH 9.8 with 12N HCl, brought to 500 mL with distilled water, stored at room 
temperature) immediately before use, and 100 µL/well was added.  Plates were covered 
with aluminum foil to ensure darkness for 10 minutes thus allowing development of 
color.  Plates were read at a wave length of 405 nm (Universal Microplate 
Spectrophotometer; µQuant; BIO-TECH Instruments, Inc., Winooski, VT).   
Serum samples analyzed by ELISA were from prebleed (d 0), day 13, 35, 47, and 
84 from 10 randomly selected Rambouillet ewes from each treatment group (200 
samples); and prebleed, day 47, 68, and 289 of all mixed breed ewes (134 samples).  
Each sheep serum sample was assigned to a row on the ELISA plate and was diluted with 
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PBSTG using 12 dilutions, beginning with 1:40 in the first well and continuing at 
doubled dilution rate to 1:81,920 for samples from days 0, 13, 68, 84, and 289.  For 
samples of days 35 and 47, first well dilution was 1:80 and continued to 1:163,840 in the 
12th well.  One ewes serum (Group 1, Day 13, ewe number R1580) with representative 
antibody response was designated as the reference serum and was repeatedly used on 
each plate to measure variability between plates and titer.  Two wells on each plate had 
everything but primary antibody (blank).  Dilutions of the sera were prepared in less 
expensive, U shaped round bottom well plates (Cooke Engeneering Co., Alexandria, VA; 
U Plate Disposable 220-24 Microtiter) and transferred to the ELISA plates using a 
multi-channel pipette.  
The highest dilution of serum when the antibody is still detectable is referred to as 
titer.  The optical density (OD) data from spectrophotometer were transformed into titers 
utilizing the OD measurements of reference serum, as described in Figure 1.   Statistical 
analysis was done using the log of titers.  
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 Figure 1.  Algorithm of IgG titer determination.   
 
1. ELISA results have Optical Density readings (OD).     
 
Sample serum A 
Sample serum B 
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Sample serum G 
        Reference serum 
     Dilutions 
 
2. For the Reference serum on each plate: 
 
• Plot the reference serum ODs against its dilutions. 
• Determine the linear part of the curve. 
• Determine dilution associated with the1/2 maximum point on the linear portion of 











• On the ELISA plate, read what Reference OD of Reference serum is associated 











• For each sample on the plate, find the reading closest to Reference OD of 1.6. 
• Read what dilution is associated with that well and record it. 
 
 
3. Move to another ELISA plate and repeat the process again. 
Reference  
     OD 
1/1280 =Reference titer 
 Dilution 
Dilution 1/1280 
OD=1.6 =Reference OD 
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VII. Statistics  
 The primary experimental hypotheses were: 
1. Immunization positively affects the pregnancy outcome. 
2. Immunization positively affects the mastitis outcome. 
The secondary experimental hypotheses: 
3. Effects of peptidoglycan and killed cells on pregnancy do not differ. 
  4. Effects of peptidoglycan and killed cells on mastitis do not differ. 
Variables measured were proportion of ewes pregnant on day 42 of gestation, and 
incidence of mastitis in the middle and at the end of lactation.  Immune response was 
verified by monitoring fever and IgG antibodies.  
To test specified hypotheses, preplanned comparisons 2 and 3 indicated in Table 1 
were evaluated using Pearson Chi-square test of homogeneity and Fishers exact test for 
proportion of ewes pregnant and occurrence of mastitis 
 
Table 1.  Layout of treatments and planned contrasts for statistical analysis    
      
 
   G1           G2            G3          G4 
  Treatment/       Immunized       Immunized     Not immunized         Saline 
  Comparison            w. PG-PS       w. killed cells     challenged 
Comparison 1  -1  -1  -1  3 
Comparison 2  -1  -1   2   
Comparison 3  -1   1    
In comparison 2, homogeneity of pregnancy counts or mastitis counts is tested for all 
immunized (G1 and G2) and Not immunized, challenged (G3) ewes.  In comparison 3, 
homogeneity of pregnancy counts or mastitis counts is tested for immunized with PG-PS (G1) 
and immunized with whole killed cells (G2).   
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Logistic Regression analysis of JMP statistical software (Version 5.0, 2002, SAS 
Institute, Cary NC) was used for prediction of pregnancy from cumulative dose of PG-PS 
(day 0 + day 22 + day 47 doses in G1, G3, and G4 ewes).  Fever and antibody response 
were analyzed using repeated measures analysis of variance of SAS GLM Procedure 
(1999, SAS Institute, Carry, NC) and Chi-square test of association of JMP (2002). 
Significance level was 0.05. 
VIII. Responses of Body Temperature and Antibodies  
Body temperature (BT) was measured in rectum of ewes using digital 
thermometers every hour for 12 hours after the inoculations (day 0 and 22) and then at 24 
hours and after the challenge injection (day 47) in mixed breed ewes.  Repeated measures 
analysis of variance enabled to verify that treatment influenced BT, to determine whether 
the time after inoculation influenced BT, and whether there was a treatment by time 
interaction.  Since G3 and G4 ewes all received saline only at first and second 
inoculations, they were grouped together (G3,4 or Saline).  Body temperature changes 
after first inoculation are represented in Figure 2.  There was a significant interaction of 
treatment and time (p<0.0001).  Although BT increased within first 3 hours in all groups, 
BT continued to increase in G1 and G2.  Temperature was highest in G2 with a peak 
40.2°C at 10 hours after inoculation.  Analysis of contrasts Hour * Saline versus G1 and 
G2 and Hour * G1 versus G2 were both significant (p < 0.0001 and p < 0.01, 
respectively).  The BT was elevated after the second injection (Figure 3) in G1 and more 
so in G2 ewes, reflecting significant hour by treatment interaction (p < 0.0001).  Again, 
the contrasts Hour* Saline versus G1 and G2 was significant (p < 0.0001) as well as 
Hour * G1 versus G2 (p < 0.0001).  At the challenge injection (Figure 4), there was 
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also hour by treatment interactions, (p < 0.05).  Only Hour * Saline versus G1, G2, and 
G3 comparison was significant (p < 0.0001).  Occurrence of fever, determined by 
increase in BT > 0.7 °C from the BT before injection, was also evaluated (Lavický et al, 
1988). Summary of occurrence of fever is in Table 2.  After first inoculation, 67 % of G1, 
89 % of G2 and 47 % of Saline treated sheep had fever (p > 0.1). Distribution of 
occurrence of fever after second injection (D 22) was 44 % in G1, 100 %, in G2 and 12 
% in Saline group (p < 0.0001).  On the day of challenge injection (Day 47) all of the 
sheep in G1 and G2 had fever, 75 % of ewes challenged and not immunized (G3) had 
fever and 25 % of saline treated ewes (p < .05).  
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Table 2. Distribution of fever (increment of 0.7 ºC) occurrence in mixed breed ewes 
at the times of inoculations.    
 
Treatment    G1       G2   G3  G4                   p-  
Immunized    Immunized       Not Immunized,  Saline           value 
Day / Fever with PG-PS   with killed cells     challenged  
   
D 0    6/9 (67%)      8/9 (89%)     8/17 (47%)   0.11 
D 22   4/9 (44%)      9/9 (100%)     2/17 (12%)          <0.0001 
D 47  7/7 (100%)      9/9 (100%)        6/8 (75%)         2/8 (25%)   0.0011 
 
 
The PG-PS IgG antibody response was evaluated separately from Rambouillet 
and mixed breeds and is presented in Figures 4 and 5, respectively.  Treatment and day 
interaction was detected for both breeds (p < 0.0001 in both).  Also, titers in immunized 
animals (G1 and G2) compared to challenged not immunized ewes, differed depending 
on time in each group, (p < 0.0001 in each).  Titers for PG-PS-treated ewes (G1) 
compared to killed cells-immunized ewes (G2) differed in Rambouillet ewes (p < 0.05), 
but not in mixed breed sheep (p = 0.2).  In Rambouillet ewes, killed cells were more 
effective than PG-PS in eliciting IgG responses.  It was observed by the magnitude of 
titers, that the mixed breed ewes appeared to have stronger IgG response than 
Rambouillet ewes.   
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Figure 5.  IgG antibody titers in Rambouillet  ewes measured 
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Figure 6.  IgG antibody titers in mixed breed ewes measured 
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I. Pregnancy in Rambouillet Ewes  
Pregnancy examination in Rambouillet ewes revealed that the proportion of ewes      
pregnant did not differ significantly due to treatments (Figure 7).  Immunization was 
found ineffective on pregnancy maintenance when proportion of all immunized ewes 
(G1 and G2) pregnant, 52 %, was compared to 65% pregnant in not immunized, 
challenged group (G3).  Effect of PG-PS did not differ from effect of killed cells on  
pregnancy maintenance (47% versus 56%). 
Figure 7:  Effect of treatment on percent pregnant in 


































 The cumulative PG-PS dose (D0 + D22 + D47) was a useful predictor of 
pregnancy (p < 0.05).  With increased cumulative dose of PG-PS, proportion of ewes 
pregnant decreased as depicted in Figure 8. 
Figure 8:  Model predicting the percent of Rambouillet ewes 
pregnant from cumulative dose of PG-PS
Model: P(y) = 1/[1+e^-(-1.05 + 0.009*x)]
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II.  Pregnancy in Mixed Breed Ewes 
 Proportion of pregnant ewes did not differ significantly in four treatment groups, 
Figure 9.  The percentage immunized ewes detected pregnant (63%) was not statistically 
different from not-immunized ewes pregnant (75%, p = .67).  The PG-PS immunized 
ewes seemed to have higher pregnancy proportion (71%) than killed cells-immunized 
ewes (56%), but the difference was not significant (p = 0.63).  
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Figure 9. Effect of treatment on percent pregnant in mixed breed 
ewes 

































III. Mastitis in Mixed Breed Ewes 
Incidence of mastitis expressed in percent in Figures 10 and 11 was not 
statistically different in four treatment groups in the middle (p = 0.12) and at the end (p = 
0.32) of lactation.  Four of the fourteen immunized ewes had mastitis in the middle of 
lactation (29%), but four out of 7 (57%) ewes not immunized had mastitis, but this was 
not different when evaluated by two-tailed Fishers exact test.  At the end of lactation, 
immunized and not immunized ewes had similar incidences of mastitis, 62 and 57 %, 
respectively.  The type of immunizing agent (PG-PS versus killed cells, G1 vs. G2) did 
not affect the occurrence of mastitis in the middle, nor at the end of lactation.   
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Bacteria obtained from mastitic milk samples of 22 ewes at the end of lactation 
consisted of 28 colonies, out of which, 15 were Gram-positive (54%).  Distribution of 
bacteria-containing milk samples did not differ between treatments (p > 0.05). 
 
 
Figure 10.  Effect of treatment on occurrence of mastitis in 
mixed breed ewes, middle of lactation (39 days post partum) 




































Figure 11.  Effect of treatment on occurrence of mastitis in 
mixed breed ewes, end of lactation (98 days post partum)

































IV.  Additional Results 
Association of fever (increased body temperature by 0.7 ºC) at the time of the 
challenge (day 47) and pregnancy maintenance also was evaluated in mixed breed ewes 
using Fishers exact test.  Fifty percent of ewes (4/8) without fever were pregnant on day 
42 after breeding and 67 % of ewes that had fever after the challenge (16/24) were 
pregnant.  There was no association found between fever on day 5 and maintenance of 








Pregnancy An immune response was successfully elicited as documented by the 
formation of IgG PG-PS-reactive antibody.  Rotta (1975) proposed that PG could be used 
for the prevention of infectious diseases, because rabbits repeatedly injected with PG 
developed tolerance to fever, and mice developed resistance to infection with group A 
streptococci after PG injection.  Rotta (1975) also stated that the non-specific resistance 
of mice to infection induced by the streptococcal cell wall was dependent on PG, not the 
PS or cell wall proteins.  Baines et al. (1996) demonstrated that early embryo loss in mice 
induced by a bacterial infection (LPS) could be prevented by prior immunization with 
LPS, as long as the anti-LPS antibody titers remained above a threshold value of 1/500.  
However, the immunity was short-lived and a protective effect was lost after 5 weeks.  
Immunization with isolated PG-PS or with heat killed Strep pyogenes did not positively 
affect pregnancy outcome in Rambouillet nor in mixed breed ewes.  Moreover, the total 
amount of PG-PS ewes received lowered the probability of successful pregnancy in 
Rambouillet ewes, as shown by logistic regression analysis.  However, immunization 
with PG-PS or with killed cells did not seem to have any lasting negative carry-over 
effect on conception, because the pregnancy rate averaged across all groups on day 42 
post breeding was 95%.  This included the second service ewes, which did not conceive 
or lost their embryo at the time of the PG-PS challenge but were able to conceive at the 
next estrous.  In the group that was not immunized and was challenged on day 5 after 
breeding, 65% of ewes were pregnant on day 42.  This result is similar to 64% pregnant 
found by Barker (1999) in older ewes injected with PG-PS without immunization. 
Negative tendency of the effect of immunization may be attributed to sensitizing the 
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immune system of sheep to the PG-PS.  If that was the case and ewes were sensitized to 
the PG-PS using the immunization injections, then their bodies reacted by mounting an 
even stronger immune response at the challenge, which could be manifested by more 
inflammatory mediators with negative effect on pregnancy in ewes.  Schwab et al. (1967) 
reviewed experiments of many investigators that demonstrated certain form of chronic 
arthritis in animals using multiple or single injections of microbial agents.  One 
hypothesis of the etiology of the rheumatoid arthritis is that poorly degradable bacterial 
PG are transported to the joint and are capable of inducing abnormal immune response on 
the part of the host (cited in Hamilton et al 1982).  This results in release of inflammatory 
mediators leading to the destruction of the joint.  It may be that the nonbiodegradability 
and of bacterial PG is pathogenic factor related to negative effect of PG-PS on 
pregnancy.   
Baines et al. (1994) compared embryonic loss in mice kept in a murine pathogen 
free animal facility to that of normally housed mice and found that the number of 
implantations per pregnancy was significantly higher in mice grown in murine pathogen-
free environment.  In living systems constantly exposed to pathogens, the defense 
reactions of the host to pathogens are redundant and may cause unnecessary exaggerated 
reaction of immune system.  Thomas (cited in Jesmok and Borgia, 1985), after 
challenging horseshoe crabs with very low dose of LPS and observing a violent response, 
pointed out that it was the defense mechanism that became itself a disease and the cause 
of death.  In mammals, production of inflammatory reaction associated agents, such as 
cytokines, chemokines, prostaglandins, as well as neuropeptides and other molecules may 
directly or indirectly influence survival of a host and its embryo.    
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Results of this and other experiments related to the problem of embryonic loss 
due to exogenous pathogens lead to following postulates: 
1.  PG-PS-reactive antibodies do not guarantee protection against early loss of 
pregnancy in sheep.  Immunization with PG-PS and killed cells of Strep pyogenes 
induced the humoral immune response demonstrated by IgG antibodies to PG-PS.  
Mastitis developed during the ensuing lactation in immunized ewes.  Treated groups with 
high IgG titers did not show higher maintenance of pregnancy. 
2.  Prostaglandins, especially increased PGF2α, are involved in abortions (Skarnes 
and Harper, 1972, Giri, 1990) via regression of CL and/or via uterine smooth muscle 
contractions, and in early embryonic losses.  Barker (1999) found that lower pregnancy 
maintenance was associated with high concentrations of PGFM (prostaglandin F2α 
metabolite) in PG-PS treated ewes.  Also, Ramadan et al. (1997) observed increased 
venous PGF2α after bacterial challenge.  Kastelic (1991) reported that luteal regression 
occurred before embryo death prior to day 25 of gestation.  Starbuck (2002), based on 
ultrasonographic examination of dairy cows, suggested that when an embryo died 
between day 30 and 37, it happened before luteal regression.  Mitchell et al. (1990) 
cultured human decidua with endotoxin and inflammatory mediators (IL-1α, IL-1β, and 
TNF- α).  All of these induced significant concentration-dependent increases in PGE2 and 
PGF2α production.   
3.  Nonspecific maternal immune effector cells, macrophages and natural killer 
cells, when activated, are involved in embryonic resorption in mice (Gendron and Baines, 
1988, Gendron et al., 1990, Duclos et al., 1995).  Inflammatory mediators secreted by 
macrophages, IL-1, TNF-α and nitric oxide (NO), play an important role in embryonic 
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loss (Baines et al. 1997).  Menom et al. (1995) observed inflammatory cytokines IL-1 and 
IL-6 as well as IL-8 and TNF-α (Fortunato et al., 1996) produced by amniochorionic 
membranes of human, after E coli challenge in vitro.  A macrophage activation marker in 
the decidua of mice was expressed before early embryo loss (Haddad et al. 1997). 
4.  Nitric oxide (NO) is produced from arginine in high amounts after increases of 
certain cytokines and bacterial toxins (Nathan, 1992). It is speculated that NO inhibits 
lymphocyte apoptosis which may modulate the immune system to prolonged 
inflammatory response (reviewed by Dimmer and Zeiher, 1997).  Ando et al. (1998) 
observed that NO was elevated both in the liver and abdominal cavity after 
intraperitoneal administration of LPS.  Duclos et al. (1995) and Haddad et al. (1995) 
postulated that NO secretion by macrophages activated at the materno-fetal interface in a 
mouse could be one of many possible mechanisms by which macrophages affect 
placental development. 
5. Fever may or may not be directly related to early embryonic loss.  Fever was 
detected in the majority of inoculated animals after administration of PG-PS as well as 
killed cells at all three times of inoculation.  This is contrary to Rottas et al. (1975) 
observation of decreased fever after repeated inoculations of rabbits with PG.  However 
PG-PS and PG differ in the presence or absence of highly immunogenic PS portion.  
Even though fever was monitored for the purpose of verification of the inflammatory 
reaction to PG-PS and killed bacteria, the possibility of fever directly affecting embryo 
survival could not be excluded.  Results of this experiment as well as Barker (1999) 
showed no association of fever and pregnancy.  Similarly, Giri et al (1991) found 
intravenous endotoxin infusion in the first trimester of gestation did not affect the body 
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temperature of cows that aborted, differently than as those non-aborting.  However, 
induction of fever by partial submersion of pregnant rabbits in warm water for 20 minutes 
interrupted pregnancy Cameron (1943).  Zahl and Bjerknes (1944) suggested that fever 
induced by bacterial endotoxin caused death of the blastocyst, thus accounting for 
pregnancy loss during the pre-implantation stage.  Romero et al. (1989), based on 
reasoning that IL-1 is mediating the fever response related to preterm labor in humans, 
cultured amnion cells with IL-1 and observed concentration-dependent increases in PGE2 
production.  This group concluded that IL-1 could serve as signal for initiation of labor in 
cases of intrauterine or systemic infection.  
6. Reproductive steroid hormones, especially progesterone (P4) are involved in the 
pathology of bacteria-induced embryonic losses. Barker (1999) recognized reduced 
concentration of P4 in all PG treated ewes, but not all treated ewes lost their pregnancy.  
Kelly et al. (2001) reviewed the steroid actions and concluded that P4, to which the 
human endometrium is exposed, is a major factor governing cytokine concentrations in 
the endometrium.  Estriol was found to be regulatory on T-cell migration and cytokine 
profile in the human (Zang et al, 2002). 
 
Mastitis.  Immunization of ewes did not have a significant effect on occurrence of 
mastitis. Yancey (1999) stated that it is difficult to evaluate the success of vaccines 
against mastitis.  Whether the definition of successful vaccine should be based on 
reduction of severity of clinical symptoms, prevention of new intramammary infections, 
or spontaneous cure rate, has not been defined.  Ideally, a successful vaccine should do 
all of that.  Yancey (1999) also pointed out that specific enhancement of immune 
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response via vaccination could even worsen the mastitis.  This would explain why cows 
that had mastitis are more susceptible to infection. This sensitivity is likely an example of 
hypersensitivity.  Hypersensitivity is a harmful immune response that produces tissue 
injury and may cause serious disease (Janeway et al., 2001, p.472).  Little (1937) 
suggested that teats had to be sensitized to Strep agalactiae by exposing the teat to it 
repeatedly before establishment of infection.  Spencer and Angevine (1950) concluded 
that cows may be indeed sensitized to Strep agalactiae and that hypersensitivity to Strep 
agalactiae appears to be involved in pathogenesis of mastitis.  This was supported by the 
fact that intradermal injections of formalinized cultures produced larger and more 
persistent swelling in infected then in normal cows.  In the later report, however, Spencer 
and Simon found that prior sensitization by subcutaneous injection of living organism did 
not increase susceptibility to experimental exposure by intramammary infusion of 1,100-
24,000 organisms.   
PG-PS versus whole killed cells of Strep pyogenes.  No differences in between 
however, ewes inoculated with killed cells had slightly delayed onset and longer lasting 
fever and significantly higher IgG titers compared to PG-PS inoculated sheep.  Higher 
fever in ewes treated with killed-cells-treated can be explained by the presence of other 
pyrogenic molecules.  Higher IgG response of the G2 group of sheep related to 
differential, perhaps more effective, antigen presentation of pathogen in the case of whole 
cells, which in turn results in higher antibody response.  
Unplanned Gram-negative challenge.  During the gestation of Rambouillet sheep 
in Idaho, a Campylobacter infection outbreak occurred at the facility.  Camplylobacter, 
Gram-negative bacteria, as opposed to Gram-positive bacteria that was used to isolate the 
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PG-PS, causes late abortions in ruminants.  Only out of curiosity, possible association of 
PG-PS and gram-negative bacterial infection was numerically evaluated in terms of 
abortions.  There was no statistical association found between immunization with PG-PS 
or killed cells and distribution of late abortions and early neonatal deaths due to 
Campylobacter.  
Materials and methods effectiveness The protocol for estrous synchronization 
using progestagens, prostaglandin and gonadotropin was very successful.  Out of 200 
Rambouillet ewes synchronized, 76 % came into heat within 72 hours, 82 % within 7 
days and 95 % were pregnant on day 45-post synchronization.  The ultrasound procedure 
of evaluating pregnancy and estimating the age of the embryos had a high degree of 
accuracy. When comparing the ultrasound-estimated age of embryos to the breeding 
records, there was only a 5 days average under-estimation of the embryonic age.   
 
 In conclusion, immunization with isolated PG-PS or with heat killed Strep 
pyogenes did not positively affect the pregnancy in Rambouillet, nor in mixed breed 
ewes.  Moreover, total amount of PG-PS ewes received, lowered probability of successful 
pregnancy in Rambouillet ewes.  Incidence of mastitis was not lessened in immunized in 
mixed breed ewes during and after weaning.  Effects of killed cells and PG-PS on 
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